#COLOR ME SHOCKED IN FRANCE SKIN#

Risk factors included the use of high-absorbency tampons and prolonged, continual usage ( 3). It did not come to public attention until 1980, when an association between TSS and young menstruating women using tampons was discovered ( 2). The term ‘toxic shock syndrome’ was first coined in 1978 in a Lancet publication describing the symptom complex in children eight to 17 years of age with an acute febrile illness ( 1). Control cultures including nasal swab for S aureus remained negative. She remained stable for the next two weeks, at which point she was seen at the Infectious Diseases Outpatient Clinic at University Hospital, London Health Sciences Centre (London, Ontario). The patient remained stable on her antibiotic regimen, ultimately being discharged in good health eight days postadmission.

#COLOR ME SHOCKED IN FRANCE SKIN#

Desquamation of her skin rash began on postadmission day 4. Within 24 h of receiving clindamycin, her blood pressure had significantly improved. Subsequently, intravenous clindamycin was added to her antibiotic regimen with probable diagnosis of menstrual toxic shock syndrome (TSS). The Infectious Diseases services were consulted. Postadmission day 2, the patient developed a generalized morbilliform rash. She continued to receive aggressive intravenous fluids and was transferred to a high-acuity observational unit. She presented to the emergency department the following day, after continuing to feel unwell.ĭuring the next 24 h, the patient clinically deteriorated she had a temperature of 39.1☌, a blood pressure of 76/45 mmHg and a heart rate of 137 beats/min. By day 7, she noticed an episode of black vaginal discharge followed two days later by yellow purulent discharge along with subjective fevers, at which point she stopped using the menstrual cup. Her subsequent menses became heavier and longer than normal.

She used appropriate hygiene when handling and changing the cup, but retrospectively reported causing a small abrasion during one of her initial insertions. Ten days before her presentation, she began using The DivaCup (Diva International Inc, USA), a brand of menstrual cup for menstrual blood collection ( Figure 1). She had a history of Hashimoto’s thyroiditis and chronic menorrhagia.

A 37-year-old Caucasian woman presented to the emergency department with a two-day history of fevers, conjunctival hyperemia, abdominal cramps, myalgias, vaginal discharge and diffuse erythroderma prominent on her upper thorax, inner thighs and perineum.

Color me shocked in france